As such, KLHDC2 is emerging as a novel powerful degrader, and the hope is that through the development of potent small molecule ligands that recruit KLHDC2 to the target protein, it will be able to specifically degrade proteins involved in cancer [72]. This evidence concerns the gene KLHDC2 and cancer.